Drug Profile
Fibroblast growth factor 9
Latest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator University of Pennsylvania
- Developer Follica
- Class Fibroblast growth factors
- Mechanism of Action Cell differentiation stimulants; Signal transduction pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alopecia
Most Recent Events
- 13 Sep 2023 Discontinued - Preclinical for Alopecia in USA (Topical) (Follica pipeline; September 2023)
- 28 Mar 2018 No recent reports of development identified for preclinical development in Alopecia in USA (Topical)